Bristol-Myers Squibb Co (BMY)
41.09
+0.84
(+2.09%)
USD |
NYSE |
May 31, 16:00
41.14
+0.05
(+0.12%)
After-Hours: 20:00
Bristol-Myers Squibb Cash and Short Term Investments (Annual): 12.28B for Dec. 31, 2023
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.28B |
| December 31, 2022 | 9.253B |
| December 31, 2021 | 17.22B |
| December 31, 2020 | 16.45B |
| December 31, 2019 | 15.39B |
| December 31, 2018 | 8.759B |
| December 31, 2017 | 6.812B |
| December 31, 2016 | 6.35B |
| December 31, 2015 | 4.27B |
| December 31, 2014 | 7.435B |
| December 31, 2013 | 4.525B |
| December 31, 2012 | 2.829B |
| December 31, 2011 | 8.733B |
| December 31, 2010 | 7.301B |
| December 31, 2009 | 8.514B |
| December 31, 2008 | 8.265B |
| December 31, 2007 | 2.225B |
| December 31, 2006 | 4.013B |
| December 31, 2005 | 5.799B |
| Date | Value |
|---|---|
| December 31, 2004 | 7.474B |
| December 31, 2003 | 5.562B |
| December 31, 2002 | 3.989B |
| December 31, 2001 | 5.654B |
| December 31, 2000 | 3.385B |
| December 31, 1999 | 2.957B |
| December 31, 1998 | 2.244B |
| December 31, 1997 | 1.456B |
| December 31, 1996 | 1.681B |
| December 31, 1995 | 1.645B |
| December 31, 1994 | 1.642B |
| December 31, 1993 | 2.421B |
| December 31, 1992 | 2.137B |
| December 31, 1991 | 1.435B |
| December 31, 1990 | 596.00M |
| December 31, 1989 | 510.00M |
| December 31, 1988 | 2.512B |
| December 31, 1987 | 2.347B |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Annual) Range, Past 5 Years
9.253B
Minimum
2022
17.22B
Maximum
2021
14.12B
Average
15.39B
Median
2019
Cash and Short Term Investments (Annual) Benchmarks
| Amgen Inc | 10.94B |
| Gilead Sciences Inc | 7.264B |
| Johnson & Johnson | 22.93B |
| Eli Lilly and Co | 2.928B |
| 2seventy bio Inc | 216.99M |